IMPORTANT SAFETY INFORMATION:
Corzall™ Plus Liquid (carbetapentane citrate, pseudoephedrine hydrochloride and pyrilamine maleate) 20 mg/30 mg/7.5 mg per 5 mL is indicated for the symptomatic relief of the cough, coryza and nasal congestion associated with the common cold, sinusitis, allergic rhinitis and other upper respiratory tract conditions. Appropriate therapy should be provided for the primary disease. Corzall™ Plus Liquid should not be taken if patient is allergic to pseudoephedrine, pyrilamine or carbetapentane. Corzall Plus Liquid should not be taken by patients with severe hypertension, severe coronary heart disease, patients on monoamine oxidase (MAO) inhibitor therapy, patients with narrow-angle glaucoma, urinary retention, peptic ulcer, and during an asthma attack. Sympathomimetic amines should be used judiciously and sparingly in The elderly (60 years and older) are more likely to exhibit adverse reactions. The most common side effects are convulsions, CNS stimulation, cardiac arrhythmia, respiratory difficulties, increased heart rate or blood pressure, hallucinations, tremors, nervousness, insomnia, pallor and dysuria, nausea, other gastrointestinal disturbances and hyperexcitability, especially in children. Do not exceed recommended dosage. Before prescribing medication to suppress or modify cough, identify and provide therapy for the underlying cause of the cough and take caution that modification of cough does not increase the risk of clinical or physiologic complications. Use with caution in patients with hypertension, heart disease, asthma, hyperthyroidism, increased intraocular pressure, diabetes mellitus, and prostatic hypertrophy. Avoid alcohol and other CNS depressants while taking this product. Patients sensitive to antihistamines may experience moderate to severe drowsiness. Patients sensitive to sympathomimetics may note mild CNS stimulation. Patient should check with physician if they are pregnant or nursing.
For full prescribing information, please click here
If you do not have Adobe® Acrobat® Reader for viewing the pdfs shown above, you may download it free of charge by clicking here.
|